Wed, May 20, 2020
Tue, May 19, 2020
Mon, May 18, 2020

Chris Schott Downgraded (TXMD) to Hold on, May 19th, 2020

Chris Schott of JP Morgan, Downgraded "TherapeuticsMD, Inc." (TXMD) to Hold on, May 19th, 2020.

Chris has made no other calls on TXMD in the last 4 months.



There are 2 other peers that have a rating on TXMD. Out of the 2 peers that are also analyzing TXMD, 0 agree with Chris's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chris


  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $250 on, Thursday, May 7th, 2020
  • Annabel Samimy of "Stifel" Maintained at Strong Buy with Increased Target to $750 on, Thursday, April 16th, 2020